| The role of osteoprotegerin (OPG) receptor activator for nuclear factor kappaB ligand (RANKL) in cardiovascular pathology - a review. | |
| | |
MedLine Citation:
|
PMID: 21870142 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Initially described as key regulators in metabolic bone disease osteoprotegerin (OPG), receptor activator of nuclear factor kappa B (RANK) and RANK ligand (RANKL) have also been discriminated as regulators in immunologic function. Cardiovascular diseases (CVD) develop over many years in life and are often triggered by inflammatory processes within the vessel wall that lead to vascular remodeling. Recently some study groups have described OPG as a prognostic parameter for mortality and morbidity in cardiovascular patients. |
| | |
Authors:
|
Daniela-Eugenia Malliga; Doris Wagner; Astrid Fahrleitner-Pammer |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-9-2 |
Journal Detail:
|
Title: Wiener medizinische Wochenschrift (1946) Volume: - ISSN: 1563-258X ISO Abbreviation: - Publication Date: 2011 Sep |
Date Detail:
|
Created Date: 2011-8-26 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8708475 Medline TA: Wien Med Wochenschr Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Division of Cardiac Surgery, Department of Surgery, Medical University of Graz, Graz, Austria. |
Vernacular Title:
|
Osteoprotegerin (OPG) und Receptor Activator for Nuclear Factor kappaB Ligand (RANKL) als Risikofaktoren für Entstehung und Schweregrad einer Koronaren Herzerkrankung - ein Review. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Guide values for heart rate and blood pressure with reference to 20, 40, 60 und 80% of maximum exert...
Next Document: Acute renal artery aneurysm rupture - a rare differential diagnosis of acute appendicitis.